Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BLTE

Belite Bio (BLTE)

Belite Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLTE
DateTimeSourceHeadlineSymbolCompany
07/02/202522:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BLTEBelite Bio Inc
07/02/202500:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
06/02/202514:35GlobeNewswire Inc.Belite Bio Announces Registered Direct Offering of $15 MillionNASDAQ:BLTEBelite Bio Inc
28/01/202509:19Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:BLTEBelite Bio Inc
21/01/202522:02Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BLTEBelite Bio Inc
21/01/202522:01Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BLTEBelite Bio Inc
03/01/202508:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
03/01/202508:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
27/11/202419:00GlobeNewswire Inc.Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007NASDAQ:BLTEBelite Bio Inc
21/11/202410:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
20/11/202410:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
12/11/202417:00GlobeNewswire Inc.Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:BLTEBelite Bio Inc
06/11/202400:00GlobeNewswire Inc.Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
04/11/202422:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
04/11/202408:00GlobeNewswire Inc.Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross ProceedsNASDAQ:BLTEBelite Bio Inc
14/10/202423:00GlobeNewswire Inc.Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingNASDAQ:BLTEBelite Bio Inc
09/10/202408:48Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:BLTEBelite Bio Inc
09/10/202408:46Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:BLTEBelite Bio Inc
08/10/202423:00GlobeNewswire Inc.Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual SummitNASDAQ:BLTEBelite Bio Inc
04/10/202410:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
04/10/202410:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
01/10/202420:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BLTEBelite Bio Inc
26/09/202422:51GlobeNewswire Inc.Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:BLTEBelite Bio Inc
21/09/202402:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
18/09/202401:22GlobeNewswire Inc.International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024NASDAQ:BLTEBelite Bio Inc
10/09/202422:00GlobeNewswire Inc.Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt DiseaseNASDAQ:BLTEBelite Bio Inc
05/09/202402:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
03/09/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
03/09/202422:00GlobeNewswire Inc.Belite Bio to Participate in Three Upcoming Investor ConferencesNASDAQ:BLTEBelite Bio Inc
01/09/202422:00GlobeNewswire Inc.Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical OfficerNASDAQ:BLTEBelite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLTE